Aptevo Therapeutics (NASDAQ:APVO) reported its Q2 earnings results on Thursday, August 11, 2022 at 08:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Aptevo Therapeutics missed estimated earnings by 36.84%, reporting an EPS of $-1.82 versus an estimate of $-1.33.
Revenue was down $3.11 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.4 which was followed by a 8.24% increase in the share price the next day.
Here’s a look at Aptevo Therapeutics’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -1.15 | -1.29 | -1.47 | -1.84 |
| EPS Actual | -1.55 | -1.33 | -1.43 | -1.78 |
| Revenue Estimate | 3.75M | 3.40M | 3.65M | 900K |
| Revenue Actual | 3.11M | 3.67M | 3.10M | 3.11M |
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for Aptevo Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
